These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5431051)

  • 21. Disintegration and dissolution studies on amylobarbitone tablets.
    Surén G
    Acta Pharm Suec; 1970 Nov; 7(5):483-90. PubMed ID: 5488739
    [No Abstract]   [Full Text] [Related]  

  • 22. [Editorial: Biologic availability--aspects related to general practice].
    Schmidt R
    Schweiz Rundsch Med Prax; 1974 Jun; 63(23):697-8. PubMed ID: 4838647
    [No Abstract]   [Full Text] [Related]  

  • 23. Development and optimization of the drug release determination of iron from iron prolonged release tablets.
    Kincl M; Bibic R; Veber M; Vrecer F
    Pharmazie; 2003 Apr; 58(4):257-9. PubMed ID: 12749408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Wood flour as an auxiliary substance in tablet forming. II. Effects of wood flour on some properties of tablets].
    Kolarski K; Krówczyński L
    Acta Pol Pharm; 1970; 27(5):477-86. PubMed ID: 5501744
    [No Abstract]   [Full Text] [Related]  

  • 25. [Biopharmaceutical evaluation of some tablets of acetylsalicylic acid. Importance of the method of dissolution in the establishment of the in vivo and in vitro correlations].
    Doelker E; Schwyter H; Mordier D
    Pharm Acta Helv; 1975; 50(1-2):24-7. PubMed ID: 1114158
    [No Abstract]   [Full Text] [Related]  

  • 26. Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations.
    Klueglich M; Ring A; Scheuerer S; Trommeshauser D; Schuijt C; Liepold B; Berndl G
    J Clin Pharmacol; 2005 Sep; 45(9):1055-61. PubMed ID: 16100300
    [No Abstract]   [Full Text] [Related]  

  • 27. [Biopharmaceutical study of para-aminosalicyclic acid tablets].
    Bustos D; Cid E
    Farmaco Prat; 1975 Aug; 30(8):388-97. PubMed ID: 1157916
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of juvenile iron deficiency with bivalent iron dragees (Fe2-fumarate, succinate, sulfate). Controlled double-blind study].
    Bender-Götze C
    Fortschr Med; 1980 Apr; 98(15):(590-3). PubMed ID: 7390366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopharmaceutical assessment of phenylbutazone and indomethacin preparations.
    Turakka H; Airaksinen MM
    Ann Clin Res; 1974; 6(0):suppl 11:34-43. PubMed ID: 4855463
    [No Abstract]   [Full Text] [Related]  

  • 30. [Release of drugs from tablets. I. Device estimating the release of drugs from tablets].
    Czarnecki W; Nerlo H
    Acta Pol Pharm; 1975; 32(2):227-32. PubMed ID: 1136833
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of tragacanth on disintegration time of tablets.
    Geçgil S; Bayraktar-Alpmen G
    J Pharm Belg; 1974; 29(4):352-60. PubMed ID: 4419572
    [No Abstract]   [Full Text] [Related]  

  • 32. [Medicinal capsules].
    Khanina GI; Batkina ZV; Pospelova VV; Dedukh NG
    Farmatsiia; 1974; (6):67-70. PubMed ID: 4618815
    [No Abstract]   [Full Text] [Related]  

  • 33. The varying dissolution rates of phenylbutazone tablets.
    Thomas WH; McCarthy WB
    N Z Med J; 1970 Oct; 72(461):250-3. PubMed ID: 5275017
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro comparison of the beaker, the rotating-basket and the column dissolution-rate methods.
    Bathe RV; Häfliger O; Langenbucher F; Schönleber D
    Pharm Acta Helv; 1975; 50(1-2):3-10. PubMed ID: 1114160
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on a sustained release principle based on an inert plastic matrix.
    Sjögren J
    Acta Pharm Suec; 1971 Jun; 8(3):153-68. PubMed ID: 5560264
    [No Abstract]   [Full Text] [Related]  

  • 36. [Equivalency of drugs and the problem of biological availability].
    Hirtz J
    Rev Prat; 1973 Nov; 23(53):7-10. PubMed ID: 4802222
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biopharmacy. Note IV. Influence of the technologic process and bile salts on the biopharmaceutic parameters in vitro of flufenamic acid in tablets].
    Arias I; Cadorniga R
    Boll Chim Farm; 1974 Feb; 113(2):82-90. PubMed ID: 4848139
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of bicarbonate, phosphate, and saline lavage solutions on the dissolution of ferrous sulfate tablets.
    Czajka PA
    J Toxicol Clin Toxicol; 1984; 22(5):447-53. PubMed ID: 6530702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives.
    Breda SA; Jimenez-Kairuz AF; Manzo RH; Olivera ME
    Int J Pharm; 2009 Apr; 371(1-2):106-13. PubMed ID: 19150493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of porous matrix substances to increase rate of solubility].
    Lippold BC; Lütschg R
    Pharmazie; 1974 Jan; 29(1):66-7. PubMed ID: 4820476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.